Brochure | April 25, 2022

Solutions For Decentralized Clinical Trials

Source: YPrime
telehealth virtual clinical trial iStock-1220238855

Decentralized clinical trial (DCT) models enable patients to enroll and participate in clinical trials from home or significantly reduce traveling to a central investigator site. COVID-19 caused a significant disruption in clinical development and a strain on the entire health care system, factors that helped to accelerate industry’s adoption of the decentralized strategy. DCTs require careful consideration on design and execution — from protocol development to technologies to enroll and monitor patients, collect patient data remotely, and manage clinical supplies.

Design and Execution of DCTs

DCTs pose unique challenges that could potentially increase the burden on patients, sites, and sponsors if not carefully considered and addressed. YPrime has the expertise to design and execute effective DCT strategies that take full advantage of the benefits of technology while meeting regulatory requirements and expectations.

  • Our scientific experts help clients focus on those endpoints and timepoints that answer the most important research questions and meet regulatory expectations
  • Our patient insights and engagement team develops trial strategies and tools to keep patients more informed, boost compliance, and improve retention
  • Our data science team are leaders in building new protocol specific integrations with other platforms, medical devices, and applications

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader